Genetic and biochemical studies on the activation and cytotoxic mechanism of bredinin, a potent inhibitor of purine biosynthesis in mammalian cells
- 1 December 1983
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 32 (23) , 3547-3553
- https://doi.org/10.1016/0006-2952(83)90301-5
Abstract
No abstract availableFunding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 17 references indexed in Scilit:
- Tunicamycin-resistant mutations in mouse FM3A cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1982
- Inducer-responsive expression of the cloned human interferonβ1gene introduced into cultured mouse cellsNucleic Acids Research, 1982
- High frequency of mutation to tubercidin resistance in CHO cellsSomatic Cell and Molecular Genetics, 1979
- Genetic and biochemical studies with the adenosine analogs toyocamycin and tubercidin: Mutation at the adenosine kinase locus in Chinese hamster cellsSomatic Cell and Molecular Genetics, 1978
- Anti-arthritic activity of bredinin, an immunosuppressive agentCellular and Molecular Life Sciences, 1977
- Synthesis and cytotoxicity of bredinin 5'-monophosphate.CHEMICAL & PHARMACEUTICAL BULLETIN, 1976
- Mode of action of bredinin with guanylic acid on L5178Y mouse leukemia cells.The Journal of Antibiotics, 1976
- Effect of bredinin and its aglycone on L5178Y cells.The Journal of Antibiotics, 1975
- Studies on bredinin. I. Isolation, characterization and biological properties.The Journal of Antibiotics, 1974
- Purification and properties of 5-phosphoribosylpyrophosphate amidotransferase from adenocarcinoma 755 cellsBiochemistry, 1969